Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403231 · ClinicalTrials.gov registry record · NA
INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT03403231: Completed NA study, sponsored by VA Office of Research and Development.
NCT03403231 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03403231, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
This study will evaluate a VA MyHealtheVet Secure Messaging intervention that uses different intervention messaging strategies designed to increase engagement in behaviors to prevent type 2 diabetes. The investigators will enroll 144 eligible Veterans into a 12-week MyHealtheVet Secure Messaging intervention. Eligible Veterans include those who are currently using MyHealtheVet secure messaging, meet inclusion/exclusion criteria, and have received an HbA1c test within the last 6 months that meets the ADA/CDC classification for prediabetes. Study participants will be surveyed about their engagement in behaviors to prevent TDM2 and mediators of this engagement. After completing a baseline survey, participants will be randomly assigned to receive different novel presentations of information about ways to prevent T2DM through both Secure Messaging and US Mail. The investigators will test the 5 presentations that each: (1) represent an innovative approach from behavioral economics or health psychology with great promise to increase engagement in behaviors to prevent T2DM among patients with prediabetes; and (2) have not been tested in this setting.
Interventions
- BEHAVIORAL INVENT Secure Messaging Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2020-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03403231
The ClinicalTrials.gov registry entry for NCT03403231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVENT Secure Messaging Intervention is the first listed.
NCT03403231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03403231 about?
NCT03403231 is a clinical study titled "INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)". This study will evaluate a VA MyHealtheVet Secure Messaging intervention that uses different intervention messaging strategies designed to increase engagement in behaviors to prevent type 2 diabetes. The investigators will enroll 144 eligible Veterans into a 12-week MyHealtheVet Secure Messaging in...
What is the current status of trial NCT03403231?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2018-02-01. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT03403231?
The interventions under investigation include: INVENT Secure Messaging Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03403231?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.